![Malcolm Meyn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Malcolm A. Meyn founded Amalgent Therapeutics LLC in 2020, where he is working as Chief Scientific Officer from 2020.
Malcolm Meyn active positions
| Companies | Position | Start |
|---|---|---|
Amalgent Therapeutics LLC
 Amalgent Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pain management company that is developing innovative oral pain therapeutics | Founder | 2019-12-31 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Amalgent Therapeutics LLC
Amalgent Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pain management company that is developing innovative oral pain therapeutics | Health Technology |
- Stock Market
- Insiders
- Malcolm Meyn
